Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003709 |
---|---|
Receipt number | R000004489 |
Scientific Title | Prospective observational study on efficacy and safety of PEGASYS/COPEGUS for non-responder/relapser to pegylated interferon or non pegylated interferon plus ribavirin |
Date of disclosure of the study information | 2010/06/05 |
Last modified on | 2019/09/19 09:21:09 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/06/04 15:24:19 | ||
2 | Update | 2010/06/11 10:32:05 | Acronym Acronym |
|
3 | Update | 2010/06/11 14:39:06 | Last name of lead principal investigator Organization Organization Division name Division name Address Address Organization1 Address1 |
|
4 | Update | 2010/06/11 14:42:03 | Last name of lead principal investigator Organization |
|
5 | Update | 2010/06/11 14:42:39 | Acronym |
|
6 | Update | 2010/07/16 19:06:16 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
7 | Update | 2010/07/16 19:10:19 | Narrative objectives1 Primary outcomes Primary outcomes |
|
8 | Update | 2010/07/16 19:15:26 | Name of person sending information Organization Division name Address |
|
9 | Update | 2010/07/16 19:20:29 | Key inclusion criteria Key exclusion criteria |
|
10 | Update | 2010/07/16 19:24:39 | Other related information Other related information |
|
11 | Update | 2011/12/16 13:44:56 | Recruitment status |
|
12 | Update | 2011/12/16 13:47:52 | Research ethics review Post marketing survey by drug manufacture etc., specified by Japanese law. Organization1 Address1 Tel1 Email1 |
|
13 | Update | 2013/05/27 18:16:01 | Last name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person Address Address |
|
14 | Update | 2019/04/04 17:11:32 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Division name Division name Zip code Address TEL Last name of contact person Last name of contact person Division name Division name Zip code Address Address TEL Name of primary person or sponsor Organization Organization Organization Address Address Tel |
|
15 | Update | 2019/04/04 17:44:00 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
16 | Update | 2019/04/04 17:44:42 | Date of IRB |
|
17 | Update | 2019/04/05 16:42:12 | Division name Division name Name of person sending information Name of person sending information Division name Division name Address |
|
18 | Update | 2019/04/05 16:52:20 | UMIN ID1 |
|
19 | Update | 2019/09/19 09:21:09 | Recruitment status |